In studies that provided the full range of viral loads in partners with HIV, at least 80% of transmissions involved viral loads greater than 10,000 copies/mL. Co-author Dr Lara Vojnov, of WHO, said: ...

Systematic review of 8 studies in more than 7,700 serodiscordant couples in 25 countries finds people living with HIV with viral loads less than 1,000 copies/mL have almost zero risk of transmitting ...

Reviewed by Carrie D. Johnston, MD, MS, Assistant Professor in the Division of Infectious Diseases at Weill Cornell Medical College in New York City. "Medical Journeys" is a set of clinical resources ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Testing viral loads to monitor the response to anti-retroviral therapy (ART) directed against human immunodeficiency virus (HIV) has been vital for consistent suppression of viremia, which in turn can ...

In a recent study published in Molecular Biology and Evolution, researchers investigated whether denser intrahost human immunodeficiency virus (HIV) populations had a higher incidence of coinfection ...

Researchers have identified a positive correlation between viral load and the rate at which genetic diversity increases within intrahost HIV populations. HIV has been historically difficult to treat ...

Key Takeaways Modern HIV treatment helps people live long, healthy lives. Antiretroviral therapy (ART) helps control HIV, protect the immune system, and improve long-term health outcomes. U=U ...

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect ...